{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:26:05Z","timestamp":1794957965106,"version":"4.9.1"},"reference-count":65,"publisher":"Cambridge University Press (CUP)","issue":"8","license":[{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0033291718001812_sec_a1\"><jats:title>Background<\/jats:title><jats:p>Cardiovascular diseases represent a major health issue in patients with schizophrenia (SCZ) and bipolar disorder (BD), but the exact nature of cardiometabolic (CM) abnormalities involved and the underlying mechanisms remain unclear. Psychiatric medications are known risk factors, but it is unclear whether there is a connection between the disorders (SCZ\/BD) themselves and CM abnormalities.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291718001812_sec_a2\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>Using polygenic risk scores and linkage disequilibrium score regression, we investigated the shared genetic bases of SCZ and BD with 28 CM traits. We performed Mendelian randomization (MR) to elucidate causal relationships between the two groups of disorders. The analysis was based on large-scale meta-analyses of genome-wide association studies. We also identified the potential shared genetic variants and inferred the pathways involved.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291718001812_sec_a3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>We found tentative polygenic associations of SCZ with glucose metabolism abnormalities, adverse adipokine profiles, increased waist-to-hip ratio and visceral adiposity (false discovery rate or FDR&lt;0.05). However, there was an inverse association with body mass index. For BD, we observed several polygenic associations with favorable CM profiles at FDR&lt;0.05. MR analysis showed that SCZ may be causally linked to raised triglyceride and that lower fasting glucose may be linked to BD. We also identified numerous single nucleotide polymorphisms and pathways shared between SCZ\/BD with CM traits, some of which are related to inflammation or the immune system.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291718001812_sec_a4\" sec-type=\"conclusion\"><jats:title>Conclusions<\/jats:title><jats:p>Our findings suggest that SCZ patients may be genetically predisposed to several CM abnormalities independent of medication side effects. On the other hand, CM abnormalities in BD may be more likely to be secondary. However, the findings require further validation.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0033291718001812","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T05:40:56Z","timestamp":1532583656000},"page":"1286-1298","source":"Crossref","is-referenced-by-count":76,"title":["Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits"],"prefix":"10.1017","volume":"49","author":[{"given":"Hon-Cheong","family":"So","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan-Long","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Kiu","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheuk-Hei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pak-Chung","family":"Sham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"key":"S0033291718001812_ref59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2012.12050620","article-title":"Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators","volume":"170","author":"Vancampfort","year":"2013","journal-title":"American Journal of Psychiatry"},{"key":"S0033291718001812_ref31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2011.06.008","article-title":"Life expectancy among persons with schizophrenia or bipolar affective disorder","volume":"131","author":"Laursen","year":"2011","journal-title":"Schizophrenia Research"},{"key":"S0033291718001812_ref28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fncel.2013.00004","article-title":"ErbB1-4-dependent EGF\/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease","volume":"7","author":"Iwakura","year":"2013","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"S0033291718001812_ref35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophrenia Research"},{"key":"S0033291718001812_ref53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.schres.2008.02.013","article-title":"Are metabolic indices different between drug-naive first-episode psychosis patients and healthy controls?","volume":"102","author":"Sengupta","year":"2008","journal-title":"Schizophrenia Research"},{"key":"S0033291718001812_ref43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","article-title":"Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis","volume":"74","author":"Pillinger","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"S0033291718001812_ref55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0447.2006.00784.x","article-title":"Height, weight and body mass index in early adulthood and risk of schizophrenia","volume":"114","author":"Sorensen","year":"2006","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"S0033291718001812_ref42","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S2215-0366(16)30262-0","article-title":"The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis","volume":"3","author":"Perry","year":"2016","journal-title":"The Lancet. Psychiatry"},{"key":"S0033291718001812_ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/943162"},{"key":"S0033291718001812_ref33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jad.2007.12.233","article-title":"Prevalence and correlates of overweight in drug-naive patients with bipolar disorder","volume":"110","author":"Maina","year":"2008","journal-title":"Journal of Affective Disorders"},{"key":"S0033291718001812_ref5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2016.05.001","article-title":"Transethnic genetic-correlation estimates from summary statistics","volume":"99","author":"Brown","year":"2016","journal-title":"American Journal Human Genetics"},{"key":"S0033291718001812_ref39","first-page":"25","article-title":"Medical risk in patients with bipolar disorder and schizophrenia","volume":"67","author":"Newcomer","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0033291718001812_ref3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"International Journal Epidemiology"},{"key":"S0033291718001812_ref2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.psyneuen.2015.03.012","article-title":"Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: a meta-analysis","volume":"56","author":"Bartoli","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"S0033291718001812_ref23","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1038\/srep32730","article-title":"Body mass index and psychiatric disorders: a Mendelian randomization study","volume":"6","author":"Hartwig","year":"2016","journal-title":"Scientific Reports"},{"key":"S0033291718001812_ref61","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.schres.2014.08.021","article-title":"A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism","volume":"159","author":"Vincenzi","year":"2014","journal-title":"Schizophrenia Research"},{"key":"S0033291718001812_ref4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genetic Epidemiology"},{"key":"S0033291718001812_ref15","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/bioinformatics\/btu848","article-title":"PRSice: polygenic risk score software","volume":"31","author":"Euesden","year":"2015","journal-title":"Bioinformatics (Oxford, England)"},{"key":"S0033291718001812_ref9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/schbul\/sbu016","article-title":"Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder","volume":"40","author":"Cardno","year":"2014","journal-title":"Schizophrenia Bulletin"},{"key":"S0033291718001812_ref21","doi-asserted-by":"crossref","first-page":"e00160","DOI":"10.1016\/j.heliyon.2016.e00160","article-title":"Greater variation in affect is associated with lower fasting plasma glucose","volume":"2","author":"Gupta","year":"2016","journal-title":"Heliyon"},{"key":"S0033291718001812_ref62","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/sim.3255","article-title":"\u2018Mendelian randomization\u2019 equals instrumental variable analysis with genetic instruments","volume":"27","author":"Wehby","year":"2008","journal-title":"Statistics in Medicine"},{"key":"S0033291718001812_ref41","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajhg.2015.06.005","article-title":"A fast method that uses polygenic scores to estimate the variance explained by genome-wide marker panels and the proportion of variants affecting a trait","volume":"97","author":"Palla","year":"2015","journal-title":"American Journal of Human Genetics"},{"key":"S0033291718001812_ref25","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"S0033291718001812_ref50","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.lfs.2003.08.044","article-title":"The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia","volume":"74","author":"Ryan","year":"2004","journal-title":"Life Sciences"},{"key":"S0033291718001812_ref52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2006.05.030","article-title":"Platelet serotonin and serum lipids in psychotic mania","volume":"97","author":"Sagud","year":"2007","journal-title":"Journal of Affective Disorders"},{"key":"S0033291718001812_ref47","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ng.943","article-title":"Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4","volume":"43","year":"2011","journal-title":"Nature Genetics"},{"key":"S0033291718001812_ref45","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MED.0b013e32833de61c","article-title":"Metabolic syndrome with the atypical antipsychotics","volume":"17","author":"Pramyothin","year":"2010","journal-title":"Current Opinion in Endocrinology, Diabetes, and Obesity"},{"key":"S0033291718001812_ref40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.schres.2010.05.010","article-title":"Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia","volume":"121","author":"Padmavati","year":"2010","journal-title":"Schizophrenia Research"},{"key":"S0033291718001812_ref11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri.2016.112","article-title":"Immunoregulation by members of the TGFbeta superfamily","volume":"16","author":"Chen","year":"2016","journal-title":"Nature Reviews Immunology"},{"key":"S0033291718001812_ref57","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.psyneuen.2015.09.026","article-title":"Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis","volume":"63","author":"Stubbs","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"S0033291718001812_ref14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","article-title":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk","volume":"478","author":"Ehret","year":"2011","journal-title":"Nature"},{"key":"S0033291718001812_ref1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ajhg.2013.01.001","article-title":"Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors","volume":"92","author":"Andreassen","year":"2013","journal-title":"American Journal of Human Genetics"},{"key":"S0033291718001812_ref46","doi-asserted-by":"publisher","DOI":"10.1038\/ng1847"},{"key":"S0033291718001812_ref38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.schres.2004.03.002","article-title":"A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder","volume":"71","author":"Murray","year":"2004","journal-title":"Schizophrenia Research"},{"key":"S0033291718001812_ref8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization","volume":"40","author":"Burgess","year":"2016","journal-title":"Genetic Epidemiology"},{"key":"S0033291718001812_ref6","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.3406","article-title":"An atlas of genetic correlations across human diseases and traits","volume":"47","author":"Bulik-Sullivan","year":"2015","journal-title":"Nature Genetics"},{"key":"S0033291718001812_ref64","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0140-6736(05)67663-5","article-title":"Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study","volume":"366","author":"Yusuf","year":"2005","journal-title":"Lancet"},{"key":"S0033291718001812_ref65","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-0447.2007.01063.x","article-title":"Height and body mass index in young adulthood and risk of schizophrenia: a longitudinal study of 1 347 520 Swedish men","volume":"116","author":"Zammit","year":"2007","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"S0033291718001812_ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003919"},{"key":"S0033291718001812_ref10","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.114596"},{"key":"S0033291718001812_ref13","doi-asserted-by":"crossref","first-page":"e1002607","DOI":"10.1371\/journal.pgen.1002607","article-title":"Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45891 individuals","volume":"8","author":"Dastani","year":"2012","journal-title":"PLoS Genetics"},{"key":"S0033291718001812_ref17","first-page":"503","article-title":"Immune system and cardiovascular disease","volume":"13","author":"Fernandez-Ruiz","year":"2016","journal-title":"Nature Reviews: Cardiology"},{"key":"S0033291718001812_ref63","first-page":"40","article-title":"Cardiovascular morbidity and mortality in bipolar disorder","volume":"23","author":"Weiner","year":"2011","journal-title":"Annals of Clinical Psychiatry"},{"key":"S0033291718001812_ref32","doi-asserted-by":"publisher","DOI":"10.1521\/suli.32.3.333.22177"},{"key":"S0033291718001812_ref37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1192\/apt.bp.114.012872","article-title":"Immune abnormalities across psychiatric disorders: clinical relevance","volume":"21","author":"Mondelli","year":"2015","journal-title":"BJPsych Advances"},{"key":"S0033291718001812_ref58","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","author":"Taylor","year":"2013","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"S0033291718001812_ref34","doi-asserted-by":"crossref","first-page":"20597","DOI":"10.3390\/ijms141020597","article-title":"The epidermal growth factor receptor and its ligands in cardiovascular disease","volume":"14","author":"Makki","year":"2013","journal-title":"International Journal of Molecular Sciences"},{"key":"S0033291718001812_ref56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2007.02092.x"},{"key":"S0033291718001812_ref20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12291-012-0292-x","article-title":"Assessment of insulin resistance and metabolic syndrome in drug naive patients of bipolar disorder","volume":"29","author":"Guha","year":"2014","journal-title":"Indian Journal of Clinical Biochemistry"},{"key":"S0033291718001812_ref30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.741645"},{"key":"S0033291718001812_ref49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"S0033291718001812_ref60","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1176\/appi.ajp.2007.07020233","article-title":"Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia","volume":"164","author":"Venkatasubramanian","year":"2007","journal-title":"American Journal of Psychiatry"},{"key":"S0033291718001812_ref18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jad.2006.08.015","article-title":"Changes in plasma cholesterol in mood disorder patients: does treatment make a difference?","volume":"99","author":"Gabriel","year":"2007","journal-title":"Journal of Affective Disorders"},{"key":"S0033291718001812_ref44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1192\/bjp.bp.117.200907","article-title":"Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis","volume":"211","author":"Pillinger","year":"2017","journal-title":"The British Journal of Psychiatry"},{"key":"S0033291718001812_ref27","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw181"},{"key":"S0033291718001812_ref48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fpsyt.2014.00137","article-title":"Increased mortality in schizophrenia due to cardiovascular disease \u2013 a non-systematic review of epidemiology, possible causes, and interventions","volume":"5","author":"Ringen","year":"2014","journal-title":"Frontiers in Psychiatry"},{"key":"S0033291718001812_ref7","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genetic Epidemiology"},{"key":"S0033291718001812_ref12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"S0033291718001812_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(15)00115-7"},{"key":"S0033291718001812_ref24","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"International Journal of Epidemiology"},{"key":"S0033291718001812_ref19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.schres.2016.09.026","article-title":"Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naive patients with nonaffective psychosis","volume":"179","author":"Greenhalgh","year":"2017","journal-title":"Schizophrenia Research"},{"key":"S0033291718001812_ref22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2006.08.061","article-title":"Adiponectin and cardiovascular disease: response to therapeutic interventions","volume":"49","author":"Han","year":"2007","journal-title":"Journal of American College of Cardiology"},{"key":"S0033291718001812_ref54","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/07853890802010709","article-title":"Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization","volume":"40","author":"Smith","year":"2008","journal-title":"Annals of Medicine"},{"key":"S0033291718001812_ref51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ng.271","article-title":"Genome-wide association analysis of metabolic traits in a birth cohort from a founder population","volume":"41","author":"Sabatti","year":"2009","journal-title":"Nature Genetics"},{"key":"S0033291718001812_ref66","unstructured":"Johnson, T (2012) Efficient calculation for multi-SNP genetic risk scores. Available at https:\/\/cran.r-project.org\/web\/packages\/gtx\/vignettes\/ashg2012.pdf."}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291718001812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T09:13:35Z","timestamp":1660554815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291718001812\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0033291718001812"],"URL":"https:\/\/doi.org\/10.1017\/s0033291718001812","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,26]]}}}